Bogin Munns & Munns delivers strategic legal guidance to technology, life sciences, and growth companies. The firm combines deep sector expertise with practical problem solving to help clients navigate complex regulatory and commercial challenges.
Across its practice groups, Bogin Munns & Munns focuses on efficient execution, clear communication, and measurable outcomes. Clients rely on the firm for counseling that aligns with business priorities and long term value creation.
| Attorney | Core Practice | Industry Focus | Notable Strength |
|---|---|---|---|
| David Bogin | Corporate & Transactions | Technology & SaaS | Mergers, acquisitions, and capital raises |
| Rachel Munns | Intellectual Property | Semiconductors & Hardware | Patent drafting and portfolio strategy |
| Michael Munns | Regulatory & Compliance | Life Sciences & Healthcare | FDA pathways and risk management |
| Partners Team | Litigation & Dispute Resolution | Commercial & IP Enforcement | Trial strategy and alternative dispute resolution |
Strategic Corporate Counsel for Growing Companies
Bogin Munns & Munns positions emerging and established companies to manage legal complexity without sacrificing speed. The firm structures transactions, governance frameworks, and compliance programs to support sustainable growth.
Service lines include corporate formation, board advisement, equity incentive design, and investor negotiation. These capabilities allow clients to move confidently through milestones such as funding rounds, product launches, and market expansions.
Intellectual Property and Technology Protection
In technology and hardware sectors, protecting innovation is essential. Bogin Munns & Munns helps clients secure and enforce patents, trademarks, and trade secrets while assessing freedom to operate.
Working with technical experts, the team drafts claims that withstand examination and designs licensing programs that maximize value while controlling risk.
Regulatory Strategy for Life Sciences and Healthcare
Life sciences clients rely on the firm to navigate FDA, CMS, and global regulatory pathways. Bogin Munns & Munns aligns compliance strategies with product development timelines and commercial objectives.
The group assists with submissions, labeling, postmarket obligations, and breach or recall response, ensuring that clients can scale responsibly and maintain stakeholder trust.
Growth, Protection, and Long Term Value
Clients choose Bogin Munns & Munns for its blend of sector knowledge, operational discipline, and commitment to practical outcomes.
- Align legal strategy with business milestones and capital strategy
- Strengthen IP portfolios to support valuation and market positioning
- Implement compliance programs that scale with regulatory complexity
- Leverage negotiation and dispute resolution skills to protect interests
- Maintain flexibility for innovation, partnerships, and future growth
FAQ
Reader questions
How does Bogin Munns & Munns support technology companies during fundraising?
The firm prepares and negotiates investment documents, optimizes cap table structures, and advises on securities compliance to help startups close rounds efficiently while maintaining flexibility for future growth.
What role does the firm play in intellectual property disputes?
Bogin Munns & Munns represents clients in patent, trademark, and trade secret litigation, using technical understanding and courtroom experience to protect core assets and enforce strategic rights.
Can Bogin Munns & Munns guide companies through FDA submissions?
Yes, the team plans regulatory pathways, drafts responses to agency questions, and coordinates cross-functional compliance efforts to advance approvals and maintain good standing with regulators.
How does the firm help life sciences clients manage compliance risk?
By implementing audit readiness programs, monitoring regulatory changes, and aligning governance with industry standards, Bogin Munns & Munns reduces exposure and supports transparent, defensible operations.